2021 annual financial data
Assembly Biosciences 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,493.38%.
Operating income was -132,688,000 USD and net income was -129,855,000 USD.
Operating cash flow was -93,396,000 USD.
Get free Assembly Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,254,000 USD
- Operating income
- -132,688,000 USD
- Net income
- -129,855,000 USD
- Operating cash flow
- -93,396,000 USD